Pharmacogenetics of Irinotecan Disposition and Toxicity: A Review

E-ISSN： 2212-3938|5|3|209-217

ISSN： 1574-8847

Source： Current Clinical Pharmacology, Vol.5, Iss.3, 2010-08, pp. : 209-217

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Pharmacogenetics of irinotecan toxicity

By Marsh Sharon McLeod Howard L

Pharmacogenomics, Vol. 5, Iss. 7, 2004-10 ,pp. : 835-843

Future Medicine

Access to resources Recommend Favorite

Pharmacogenetics of Target Genes Across Doxorubicin Disposition Pathway: A Review

Current Drug Metabolism, Vol. 11, Iss. 1, 2010-01 ,pp. : 115-128

Bentham Science Publishers

Access to resources Recommend Favorite

Pharmacogenetics of irinotecan: clinical perspectives on the utility of genotyping

By Innocenti Federico Ratain Mark J

Pharmacogenomics, Vol. 7, Iss. 8, 2006-12 ,pp. : 1211-1221

Future Medicine

Access to resources Recommend Favorite

Pharmacogenetics of paraoxonases: a brief review

By Draganov D. La Du B.

Naunyn-Schmiedeberg's Archives of Pharmacology, Vol. 369, Iss. 1, 2004-01 ,pp. : 78-88

Springer Publishing Company

Access to resources Recommend Favorite

Pharmacogenetics of irinotecan: A promoter polymorphism of UGT1A1 gene and severe adverse reactions to irinotecan

By Ando Maki Hasegawa Yoshinori Ando Yuichi

Investigational New Drugs, Vol. 23, Iss. 6, 2005-12 ,pp. : 539-545

Springer Publishing Company

Access to resources Recommend Favorite